Email updates

Keep up to date with the latest news and content from BMC Geriatrics and BioMed Central.

Open Access Highly Accessed Research article

Are old-old patients with major depression more likely to relapse than young-old patients during continuation treatment with escitalopram?

Constantine G Lyketsos*, Emmanuelle Weiller, Cornelius Katona and Phillip Gorwood

BMC Geriatrics 2011, 11:2  doi:10.1186/1471-2318-11-2

PubMed Commons is an experimental system of commenting on PubMed abstracts, introduced in October 2013. Comments are displayed on the abstract page, but during the initial closed pilot, only registered users can read or post comments. Any researcher who is listed as an author of an article indexed by PubMed is entitled to participate in the pilot. If you would like to participate and need an invitation, please email info@biomedcentral.com, giving the PubMed ID of an article on which you are an author. For more information, see the PubMed Commons FAQ.

Some questions

Gerard Byrne   (2011-01-20 12:41)  University of Queensland, School of Medicine email

I think this is a useful study, with practical implications for clinicians, particularly geriatric psychiatrists. There are very few antidepressant trials with significant numbers of participants aged 75 years and over.

Three questions: 1) Did time to relapse vary as a function of the extent of white matter ischaemic changes? 2) What was the incidence of hyponatraemia in the two groups? 3) What efforts were made to assess for participant unblinding in the discontinuation phase?

Competing interests

I have served on advisory boards in relation to donepezil (Pfizer), galantamine (Janssen-Cilag), rivastigmine (Novartis) and memantine (Lundbeck). I have also been an advisor to the National Prescribing Service. I have research contracts with GSK and Medivation in relation to Alzheimer's disease clinical trials. I do not own shares in any pharmaceutical company. I have a research grant from the National Health & Medical Research Council in relation to depression and anxiety during cognitive aging and from the Alzheimer's Association (U.S.) in relation to synaptic function in AD.

top

Post a comment